Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Forst

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
International Journal of Clinical Practice. Supplement|September 16, 2009
Intensification with prandial insulinA Pfützner, T Forst
ZFA. Zeitschrift Fur Allgemeinmedizin|March 20, 1981
[The treatment of hypertension with bupranolol. Results of a daily dosage administration schedule]R Grund, H T Forst
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 14, 2009
Cardiovascular effects of disturbed insulin activity in metabolic syndrome and in type 2 diabetic patientsT Forst, C Hohberg, A Pfützner
Deutsche Medizinische Wochenschrift (1946)|February 11, 2010
[Glycemic control and cardiovascular benefit: What do we know today?]M Hanefeld, M Schönauer, T Forst
ZFA. Zeitschrift Fur Allgemeinmedizin|May 20, 1980
[Patient compliance with a free and fixed combination of isosorbide dinitrate and bupranolol]E Gill, M Bechler, H T Forst
Der Internist|March 17, 2007
[Evidence based medicine: theoretical bases and current misuse for cost cutting in the public health sector]A Pfützner, T Forst, W März, et al.
Versicherungsmedizin|October 1, 1993
[Driver's license and diabetes. Legal and social medicine aspects]A Pfützner, T Forst, P Kann, et al.
Der Internist|January 26, 2017
[Cardiovascular aspects of diabetes treatment : Finally a reason for cardiologists to be pleased]T Forst, L Plum-Mörschel, M M Weber
MMW, Munchener Medizinische Wochenschrift|March 20, 1981
[Combination of beta-receptor blocking agents and saluretica in outpatient treatment of hypertension. Results of a comparative study (author's transl)]J Hoffmann, A Schrey, R Grund, et al.
Current Medical Research and Opinion|July 19, 2006
Glycemic control and treatment failure with pioglitazone versus glibenclamide in type 2 diabetes mellitus: a 42-month, open-label, observational, primary care studyM Hanefeld, A Pfützner, T Forst, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
International Journal of Clinical Practice. Supplement|September 16, 2009
Intensification with prandial insulinA Pfützner, T Forst
ZFA. Zeitschrift Fur Allgemeinmedizin|March 20, 1981
[The treatment of hypertension with bupranolol. Results of a daily dosage administration schedule]R Grund, H T Forst
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|February 14, 2009
Cardiovascular effects of disturbed insulin activity in metabolic syndrome and in type 2 diabetic patientsT Forst, C Hohberg, A Pfützner
Deutsche Medizinische Wochenschrift (1946)|February 11, 2010
[Glycemic control and cardiovascular benefit: What do we know today?]M Hanefeld, M Schönauer, T Forst
ZFA. Zeitschrift Fur Allgemeinmedizin|May 20, 1980
[Patient compliance with a free and fixed combination of isosorbide dinitrate and bupranolol]E Gill, M Bechler, H T Forst
Der Internist|March 17, 2007
[Evidence based medicine: theoretical bases and current misuse for cost cutting in the public health sector]A Pfützner, T Forst, W März, et al.
Versicherungsmedizin|October 1, 1993
[Driver's license and diabetes. Legal and social medicine aspects]A Pfützner, T Forst, P Kann, et al.
Der Internist|January 26, 2017
[Cardiovascular aspects of diabetes treatment : Finally a reason for cardiologists to be pleased]T Forst, L Plum-Mörschel, M M Weber
MMW, Munchener Medizinische Wochenschrift|March 20, 1981
[Combination of beta-receptor blocking agents and saluretica in outpatient treatment of hypertension. Results of a comparative study (author's transl)]J Hoffmann, A Schrey, R Grund, et al.
Current Medical Research and Opinion|July 19, 2006
Glycemic control and treatment failure with pioglitazone versus glibenclamide in type 2 diabetes mellitus: a 42-month, open-label, observational, primary care studyM Hanefeld, A Pfützner, T Forst, et al.
Pageof 10